Stock virus prepn |
|
|
Cell substrates for virus growth |
|
Day 10 embryonated eggs, MDCK cells, MDCK-SIAT1 cells |
Stock virus infectivity concn and method of determination |
|
At least 106 TCID50/ml, read by RBC agglutination |
Stock storage |
|
Aliquots of bulk virus prepn |
Serum prepn |
|
|
Storage of sera following receipt |
|
−70°C, −20°C, and 4°C, 1 or 2 freeze-thaw cycles in testing laboratory |
Preassay treatment of sera |
|
Heat treatment at 56°C for 30 min, without dilution in media |
Initial serum dilution |
1:10 |
|
Sample type |
|
Sera only or plasma only |
Virus prepn |
|
|
Final virus amt per well |
100 TCID50
|
|
Vol of virus solution added per sample/well |
|
50 μl, 100 μl, or 200 μl |
Virus/serum mix incubation |
|
1 h at 37°C |
Virus/serum mix incubation on cell monolayer |
|
1 h at 37°C |
Calculated starting serum dilution |
1:10, excluding virus vol |
|
Cell prepn |
|
|
Prepn of cells |
|
Preformed monolayer |
Cell types used |
|
MDCK (ATCC), MDCK (Salisbury), MDCK-SIAT1 |
Assay diluent |
|
Coon's/Dulbecco's modified Eagle's medium, with trypsin (1/2 μg/ml), laboratory-preferred media |
Cell infection media |
|
Coon's/Dulbecco's modified Eagle's medium, with trypsin (1/2 μg/ml), laboratory-preferred media |
Assay setup |
|
|
Incubation time of assay to endpoint reading |
3 days |
|
Incubation conditions |
|
35–37°C, 5% CO2
|
No. of sample replicates |
|
Replicates preferred if available |
Endpoint estimation |
|
|
Endpoint determination |
|
Turkey/guinea pig RBC agglutination, CPE |
Endpoint calculation method |
50% neutralization |
|